Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-12
2008-10-07
Padmanabhan, Sreeni (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S443000, C514S183000
Reexamination Certificate
active
07432296
ABSTRACT:
Pharmaceutical formulations containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds corresponding to formula I, as well as to their use in the production of drugs and in related methods of treating or inhibiting pain and neurodegenerative disease.
REFERENCES:
patent: 3520922 (1970-07-01), Wagner
patent: 4223039 (1980-09-01), Rose et al.
patent: 5171854 (1992-12-01), Schmidt et al.
patent: 6232467 (2001-05-01), Petasis et al.
patent: 6277850 (2001-08-01), Lubisch et al.
patent: 0 054 812 (1982-06-01), None
patent: 0 568 136 (1993-11-01), None
patent: 0 807 621 (1997-11-01), None
patent: 1 078 917 (2001-02-01), None
patent: 53-015325 (1978-02-01), None
patent: WO 91/12002 (1991-08-01), None
patent: WO 98/11073 (1998-03-01), None
patent: WO 98/14427 (1998-04-01), None
patent: WO 98/22493 (1998-05-01), None
patent: WO 98/42673 (1998-10-01), None
patent: WO 00/24510 (2000-05-01), None
patent: WO 00 35858 (2000-06-01), None
patent: WO 01/55091 (2001-08-01), None
patent: WO 01/58875 (2001-08-01), None
patent: WO 01/90051 (2001-11-01), None
patent: WO 02/09688 (2002-02-01), None
patent: WO 02/44171 (2002-06-01), None
patent: WO 03/059891 (2003-07-01), None
STIC search document (STIC—Search—07—08).
International Search Report dated Sep. 4, 2004 (twelve (12) pages).
Bruce M. Baron, et al., “[3H]MDL 105,519, a High-Affinity Radioligand for the N-Methyl-D-aspartate Receptor-Associated Glycine Recognition Site”, The Journal of Pharmacology and Experimental Therapeutics, (1996), pp. 62-68, vol. 279, copyright 1996, The American Society for Pharmacology and Experimental Therapeutics.
David Dubuisson, et al., “The Formalin Test: A Quantitative Study of the Analgesic Effects of Morphine, Meperidine, and Brain Stem Stimulation in Rats and Cats”, Pain, (1977), pp. 161-174, vol. 4, Elsevier/North-Holland Biomedical Press.
Terrence J. Coderre, et al., “Contribution of Central Neuroplasticity to pathological Pain: Review of Clinical and Experimental Evidence”, Pain, (1993), pp. 259-285, vol. 52, Elsevier Science Publishers B.V.
Nicos A Petasis, et al., “A New and Practical Synthesis of a-Amino Acids from Alkenyl Boronic Acids”, J. Am. Chem. Soc., (1997), pp. 445-446, vol. 119.
Nicos A. Petasis, et al., “A New Synthesis of α-Arylglycines from Aryl Boronic Acids”, Tetrahedron, (1997) pp. 16463-16470, vol. 53, No. 48, Elsevier Science Ltd., PII: S0040-4020(97)01028-4.
Gordon S. Currie, et al., “Chirally Templated Boronic Acid Mannich Reaction in the Synthesis of Optically Active a-Amino Acids”, J. Chem. Soc., Perkin Trans., (2000), pp. 2982-2990, vol. 1, The Royal Society of Chemistry.
Nicos A. Petasis, et al., “One-Step Three-Component Reaction Among Organoboronic Acids, Amines and Salicylaldehydes”, Tetrahedron Letters, (2001) pp. 539-542, vol. 42, Published by Elsevier Science Ltd.
Englberger Werner
Przewosny Michael
Schiene Klaus
Sundermann Bernd
Crowell & Moring LLP
Gruenenthal GmbH
Padmanabhan Sreeni
Ramachandra Umamaheswari
LandOfFree
Pharmaceutical formulations containing substituted... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical formulations containing substituted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulations containing substituted... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4003315